HIF1A and neoplasm: TKIs have the potential to reshape the tumor microenvironment (TME) by modulating various components, including tumor‐infiltrating immune cells, immunomodulatory stromal cells, cytokines, chemokines, and other factors, such as hypoxia‐inducible factor‐1α (HIF‐1α).171, 172, 173